Finoxib-TH Tablet

Resumen del producto

About Finoxib-TH Tablet

Finoxib-TH Tablet is a medication containing the active ingredient Etoricoxib, classified as COX-2 selective NSAID medication. Etoricoxib, sold under brand names including Arcoxia, Exinef and Nucoxia is a selective COX-2 inhibitor developed and commercialized by Merck. It is approved in 63 countries worldwide as of 2007, except the United States where the Food and Drug Administration sent a Non Approvable Letter to Merck and required them to….

Key Benefits & Uses

• Used for: Etoricoxib, sold under brand names including Arcoxia, Exinef and Nucoxia is a selective COX-2 inhibitor developed and commercialized by Merck
• Used for: It is approved in 63 countries worldwide as of 2007, except the United States where the Food and Drug Administration sent a Non Approvable Letter to.
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Etoricoxib, the active ingredient in Finoxib-TH Tablet, belongs to the COX-2 selective NSAID medication class. Its clinical use follows the authorised labelling for Etoricoxib-containing medicines. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Finoxib-TH Tablet. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Finoxib-TH Tablet for extended periods without medical advice.